|
RBM43 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.381200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.149850E-02 |
| Normal-vs-Stage2 |
2.074400E-01 |
| Normal-vs-Stage3 |
5.978900E-03 |
| Normal-vs-Stage4 |
8.897200E-03 |
| Stage1-vs-Stage2 |
5.096000E-01 |
| Stage1-vs-Stage3 |
5.043400E-01 |
| Stage1-vs-Stage4 |
3.930000E-01 |
| Stage2-vs-Stage3 |
2.973000E-01 |
| Stage2-vs-Stage4 |
2.816400E-01 |
| Stage3-vs-Stage4 |
8.401200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.058390E-03 |
| Normal-vs-AfricanAmerican |
5.981200E-01 |
| Normal-vs-Asian |
3.892100E-02 |
| Caucasian-vs-AfricanAmerican |
9.540000E-02 |
| Caucasian-vs-Asian |
6.501400E-01 |
| AfricanAmerican-vs-Asian |
2.489400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.554400E-02 |
| Normal-vs-Female |
4.323000E-03 |
| Male-vs-Female |
6.346600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.243560E-02 |
| Normal-vs-Age(41-60Yrs) |
2.138000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.866010E-02 |
| Normal-vs-Age(81-100Yrs) |
1.052570E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.241200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.782000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.418400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.935600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.747200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.187400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.739800E-01 |
| Classical-VS-Follicular |
5.753400E-01 |
| Classical-VS-Other |
6.699600E-01 |
| Classical-VS-Normal |
9.715900E-03 |
| Tall-VS-Follicular |
2.384000E-01 |
| Tall-VS-Other |
9.803200E-01 |
| Tall-VS-Normal |
2.444200E-02 |
| Follicular-VS-Other |
6.088000E-01 |
| Follicular-VS-Normal |
1.300050E-01 |
| Other-VS-Normal |
2.351400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.088200E-02 |
| Normal-vs-N1 |
2.154300E-04 |
| N0-vs-N1 |
8.597700E-03 |
|
|
